InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by LONGENECKER JOHN P PHD, Director. Insider active across 2 companies, notably Pacira BioSciences, Inc.. Cumulatively, 4 reports have been logged. Split: 1 buy · 0 sell. Activity tracked since 9 June 2021. The latest transaction was disclosed on 3 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
7,000 shares@ US$10.810.0064% mcap100.0% of flowCommon StockSEC:0001209191-22-016873:0
1,066 shares0Common StockSEC:0001209191-21-040087:0
1,066 shares0Common StockSEC:0001209191-21-040087
300 sharesCommon StockSEC:0001209191-16-091536:0
Ideal exit: 8 Oct 2016 (T+270)
4 of 4 declarations
About LONGENECKER JOHN P PHD
John P. Longenecker, PhD, is a Board Member at Pacira BioSciences, Inc. He brings his expertise in research and development, contributing to the strategic direction of the company. His role is crucial in supporting innovation and growth in the biopharmaceutical sector.
